institutionid,scoredate,scoretype,aspectname,scorevalue,gvkey,ticker,companyname
4152157,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,EP - Biological Oxygen Demand,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Energy Use,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Materiality,56,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Quantitative Data,67,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Hazardous Waste,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),66,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Low-Carbon Products,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sustainability Reporting Assurance,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Water Use,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Analysis of Risks,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Audit Conflict of Interest,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Effectiveness,63,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Gender Diversity,50,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,CEO-to-Employee Pay Ratio,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corporate Governance Policy,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Customer Feedback Process,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Customer Satisfaction Measurement,48,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,ESG Integration in SCM Strategy,53,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Innovation,,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Open Innovation,98,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Opportunities,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Product Innovations (Healthcare),28,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Development Stages,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Post-Launch,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Spending,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Responsibility Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Risk Response Strategy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sales Channels Variety & Innovation,60,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sales Effectiveness Targets,40,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Service Orientation,91,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supplier Risk Management Measures,49,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supply Chain Risk Exposure,73,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supply Chain Transparency & Reporting,21,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,75,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Business and Human Rights,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,CEO Compensation - Success Metrics,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corporate Citizenship Strategy,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Employee Support Programs,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Fair Pricing,36,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Healthy Lifestyle Incentive,88,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Measure Contribution to Health Outcome,33,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Network Orientation,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Partnerships for Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Percentage of Performance Related Compensation for each E,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Personal and Organizational Learning and Development,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Assurance,25,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Materiality,32,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Quantitative Data,36,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Governance,53,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Implementation,30,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Review,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Trend of Employee Wellbeing,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Workforce Breakdown: Gender,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Economic Governance Dimension,83,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Social Dimension,72,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Climate Strategy,84,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Environmental Policy & Management Systems,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Environmental Reporting,77,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Operational Eco-Efficiency,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Corporate Governance,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Customer Relationship Management,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Innovation Management,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Marketing Practices,92,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Access to Healthcare,89,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Addressing Cost Burden,18,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,86,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Health Outcome Contribution,66,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Human Capital Development,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Labor Practice Indicators,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Occupational Health & Safety,97,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Social Reporting,48,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Stakeholder Engagement,71,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Talent Attraction & Retention,79,024468,BIIB,Biogen Inc.
4152157,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,EP - Biological Oxygen Demand,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Energy Use,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Materiality,56,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Reporting - Quantitative Data,67,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Hazardous Waste,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),66,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Low-Carbon Products,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sustainability Reporting Assurance,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Water Use,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Analysis of Risks,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Audit Conflict of Interest,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Effectiveness,63,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Gender Diversity,50,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,CEO-to-Employee Pay Ratio,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corporate Governance Policy,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Customer Feedback Process,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Customer Satisfaction Measurement,48,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,ESG Integration in SCM Strategy,53,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Environmental Innovation,,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Open Innovation,98,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Opportunities,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Product Innovations (Healthcare),28,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Development Stages,78,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Post-Launch,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,R&D Spending,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Responsibility Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Risk Response Strategy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sales Channels Variety & Innovation,60,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sales Effectiveness Targets,40,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Service Orientation,91,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supplier Risk Management Measures,49,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supply Chain Risk Exposure,73,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Supply Chain Transparency & Reporting,21,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,75,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Business and Human Rights,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,CEO Compensation - Success Metrics,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Corporate Citizenship Strategy,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Employee Support Programs,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Fair Pricing,36,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Healthy Lifestyle Incentive,88,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Measure Contribution to Health Outcome,33,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Network Orientation,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Partnerships for Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Percentage of Performance Related Compensation for each E,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Personal and Organizational Learning and Development,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Assurance,25,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Materiality,32,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Social Reporting - Quantitative Data,36,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Governance,53,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Implementation,30,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Stakeholder Engagement Review,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Trend of Employee Wellbeing,85,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Question,Workforce Breakdown: Gender,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Economic Governance Dimension,83,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Dimension,Social Dimension,72,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Climate Strategy,84,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Environmental Policy & Management Systems,93,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Environmental Reporting,77,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Operational Eco-Efficiency,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Corporate Governance,90,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Customer Relationship Management,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Innovation Management,80,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Marketing Practices,92,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Access to Healthcare,89,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Addressing Cost Burden,18,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,86,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Health Outcome Contribution,66,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Human Capital Development,76,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Labor Practice Indicators,94,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Occupational Health & Safety,97,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Social Reporting,48,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Stakeholder Engagement,71,024468,BIIB,Biogen Inc.
4152157,2013-09-12,Criteria,Talent Attraction & Retention,79,024468,BIIB,Biogen Inc.
4152157,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,80,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,EP - Biological Oxygen Demand,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Materiality,73,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Low-Carbon Products,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Waste Disposal,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Water Use,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Analysis of Risks,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Audit Conflict of Interest,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Diversity Policy,60,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Gender Diversity,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,CEO-to-Employee Pay Ratio,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Compliance to Regulatory Standards,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corporate Governance Policy,80,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Customer Feedback Process,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Customer Satisfaction Measurement,28,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,ESG Integration in SCM Strategy,53,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Innovation,,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,33,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Open Innovation,98,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Opportunities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Product Innovations (Healthcare),35,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Development Stages,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Ideation or Applied Research,58,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Post-Launch,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Spending,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Responsibility Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Risk Response Strategy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sales Channels Variety & Innovation,67,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sales Effectiveness Targets,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Service Orientation,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supplier Risk Management Measures,46,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supply Chain Risk Exposure,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supply Chain Transparency & Reporting,23,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Taxation Governance & Risks,25,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Business and Human Rights,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,CEO Compensation - Success Metrics,77,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,65,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Development Programs,60,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Support Programs,76,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Fair Pricing,36,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Gender Pay Indicators,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,HTA Support of Value Proposition,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Healthy Lifestyle Incentive,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Labor KPIs - Layoffs,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Measure Contribution to Health Outcome,48,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Network Orientation,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,40,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Partnerships for Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Percentage of Performance Related Compensation for each E,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Public Commitment to Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Return on Employee Development Investment,15,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Assurance,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Materiality,30,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Quantitative Data,47,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Governance,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Implementation,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Review,94,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Training & Development Inputs,75,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Trend of Employee Wellbeing,96,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Environmental Dimension,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Social Dimension,75,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Climate Strategy,84,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Environmental Policy & Management Systems,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Environmental Reporting,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Operational Eco-Efficiency,99,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Corporate Governance,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Customer Relationship Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Innovation Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Marketing Practices,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Product Quality & Recall Management,83,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Supply Chain Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Tax Strategy,36,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Access to Healthcare,89,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Addressing Cost Burden,32,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Health Outcome Contribution,71,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Human Capital Development,53,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Labor Practice Indicators,95,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Occupational Health & Safety,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Social Reporting,44,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Stakeholder Engagement,86,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Talent Attraction & Retention,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,80,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,EP - Biological Oxygen Demand,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Materiality,73,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Low-Carbon Products,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Waste Disposal,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Water Use,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Analysis of Risks,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Audit Conflict of Interest,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Diversity Policy,60,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Gender Diversity,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,CEO-to-Employee Pay Ratio,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Compliance to Regulatory Standards,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corporate Governance Policy,80,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Customer Feedback Process,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Customer Satisfaction Measurement,28,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,ESG Integration in SCM Strategy,53,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Environmental Innovation,,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,33,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Open Innovation,98,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Opportunities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Product Innovations (Healthcare),35,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Development Stages,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Ideation or Applied Research,58,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Post-Launch,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,R&D Spending,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Responsibility Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Risk Response Strategy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sales Channels Variety & Innovation,67,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sales Effectiveness Targets,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Service Orientation,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supplier Risk Management Measures,46,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supply Chain Risk Exposure,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Supply Chain Transparency & Reporting,23,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Taxation Governance & Risks,25,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Business and Human Rights,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,CEO Compensation - Success Metrics,77,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,65,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Development Programs,60,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Support Programs,76,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Fair Pricing,36,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Gender Pay Indicators,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,HTA Support of Value Proposition,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Healthy Lifestyle Incentive,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Labor KPIs - Layoffs,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Measure Contribution to Health Outcome,48,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Network Orientation,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,40,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Partnerships for Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Percentage of Performance Related Compensation for each E,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Public Commitment to Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Return on Employee Development Investment,15,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Assurance,0,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Materiality,30,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Social Reporting - Quantitative Data,47,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Governance,78,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Implementation,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Stakeholder Engagement Review,94,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Training & Development Inputs,75,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Trend of Employee Wellbeing,96,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Environmental Dimension,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Dimension,Social Dimension,75,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Climate Strategy,84,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Environmental Policy & Management Systems,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Environmental Reporting,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Operational Eco-Efficiency,99,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Corporate Governance,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Customer Relationship Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Innovation Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Marketing Practices,93,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Product Quality & Recall Management,83,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Risk & Crisis Management,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Supply Chain Management,74,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Tax Strategy,36,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Access to Healthcare,89,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Addressing Cost Burden,32,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,90,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Health Outcome Contribution,71,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Human Capital Development,53,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Labor Practice Indicators,95,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Occupational Health & Safety,70,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Social Reporting,44,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Stakeholder Engagement,86,024468,BIIB,Biogen Inc.
4152157,2014-09-11,Criteria,Talent Attraction & Retention,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Coverage of Environmental Management Policy,44,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,EP - Biological Oxygen Demand,99,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Materiality,59,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sustainability Reporting Assurance,60,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Water Use,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Diversity Policy,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Type,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,CEO Compensation - Success Metrics,34,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Compliance to Regulatory Standards,84,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Customer Satisfaction Measurement,20,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing,36,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,ESG Integration in SCM Strategy,72,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,33,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Open Innovation,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Opportunities,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Product Innovations (Healthcare),70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Post-Launch,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Responsibilities and Committees,55,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sales Channels Variety & Innovation,94,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sales Effectiveness Targets,88,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Service Orientation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supplier Risk Management Measures,51,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supply Chain Risk Exposure,78,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supply Chain Transparency & Reporting,38,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Taxation Governance & Risks,25,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Business and Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Development Programs,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Support Programs,63,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Gender Pay Indicators,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,HTA Support of Value Proposition,25,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Human Capital Return on Investment,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Labor KPIs - Layoffs,75,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Long-Term Incentives for Employees,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Measure Contribution to Health Outcome,56,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Network Orientation,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Partnerships for Access to Healthcare,20,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Public Commitment to Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Return on Employee Development Investment,15,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Assurance,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Materiality,30,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Quantitative Data,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Governance,71,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Implementation,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Review,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Trend of Employee Wellbeing,49,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Type of Philanthropic Activities,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Social Dimension,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Climate Strategy,95,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Environmental Policy & Management Systems,77,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Environmental Reporting,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Operational Eco-Efficiency,97,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Customer Relationship Management,75,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Innovation Management,81,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Marketing Practices,89,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Product Quality & Recall Management,81,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Risk & Crisis Management,85,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Supply Chain Management,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Tax Strategy,36,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Access to Healthcare,84,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Addressing Cost Burden,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Health Outcome Contribution,73,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Human Capital Development,59,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Labor Practice Indicators,99,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Occupational Health & Safety,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Social Reporting,53,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Stakeholder Engagement,87,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Talent Attraction & Retention,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Change Governance,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Coverage of Environmental Management Policy,44,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,EMS: Certification/ Audit/ Verification,83,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,EP - Biological Oxygen Demand,99,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Materiality,59,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sustainability Reporting Assurance,60,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Water Use,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Diversity Policy,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Board Type,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,CEO Compensation - Success Metrics,34,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Compliance to Regulatory Standards,84,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Customer Satisfaction Measurement,20,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing,36,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,ESG Integration in SCM Strategy,72,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,33,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Open Innovation,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Opportunities,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Product Innovations (Healthcare),70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,R&D Post-Launch,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Responsibilities and Committees,55,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sales Channels Variety & Innovation,94,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sales Effectiveness Targets,88,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Service Orientation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supplier Risk Management Measures,51,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supply Chain Risk Exposure,78,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Supply Chain Transparency & Reporting,38,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Taxation Governance & Risks,25,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Access to Genetic Resources,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Benefits Sharing,,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Bioethics Policy,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Business and Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Development Programs,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Support Programs,63,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Gender Pay Indicators,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,HTA Support of Value Proposition,25,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Human Capital Return on Investment,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Labor KPIs - Layoffs,75,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Long-Term Incentives for Employees,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Measure Contribution to Health Outcome,56,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Measuring Benefits,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Methods (biotech),100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Network Orientation,90,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Partnerships for Access to Healthcare,20,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Public Commitment to Human Rights,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Return on Employee Development Investment,15,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Assurance,0,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Materiality,30,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Social Reporting - Quantitative Data,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Governance,71,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Implementation,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Stakeholder Engagement Review,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Trend of Employee Wellbeing,49,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Type of Philanthropic Activities,50,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Volume,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Dimension,Social Dimension,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Climate Strategy,95,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Environmental Policy & Management Systems,77,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Environmental Reporting,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Operational Eco-Efficiency,97,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Customer Relationship Management,75,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Innovation Management,81,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Marketing Practices,89,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Product Quality & Recall Management,81,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Risk & Crisis Management,85,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Supply Chain Management,76,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Tax Strategy,36,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Access to Healthcare,84,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Addressing Cost Burden,70,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Bioethics,100,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,80,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Health Outcome Contribution,73,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Human Capital Development,59,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Labor Practice Indicators,99,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Occupational Health & Safety,79,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Social Reporting,53,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Stakeholder Engagement,87,024468,BIIB,Biogen Inc.
4152157,2015-09-10,Criteria,Talent Attraction & Retention,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,81,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Change Governance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Coverage of Environmental Management Policy,55,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,EP - Biological Oxygen Demand,31,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Waste Disposal,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Water Use,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Diversity Policy,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,CEO Compensation - Success Metrics,47,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Compliance to Regulatory Standards,99,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing,39,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,ESG Integration in SCM Strategy,93,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Emerging Risks,47,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Material Issues for Enterprise Value Creation,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Open Innovation,57,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Opportunities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Product Innovations (Healthcare),73,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Post-Launch,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Responsibilities and Committees,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Service Orientation,95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supplier Risk Management Measures,51,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supply Chain Risk Exposure,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supply Chain Transparency & Reporting,60,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Tax Strategy and Governance,68,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Taxation Governance & Risks,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Access to Medicine Strategy Reporting,36,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Corporate Citizenship Strategy,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Development Programs,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Support Programs,63,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Gender Pay Indicators,93,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Governance,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,HTA Support of Value Proposition,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Assessment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Mitigation & Remediation,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Labor KPIs - Layoffs,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Local Capacity Building,27,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Measure Contribution to Health Outcome,73,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Network Orientation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Patent Filing Policy,41,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Quantitative Data,67,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Trend of Employee Wellbeing,56,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Economic Governance Dimension,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Environmental Dimension,86,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Social Dimension,79,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Climate Strategy,96,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Environmental Policy & Management Systems,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Operational Eco-Efficiency,74,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Innovation Management,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Marketing Practices,88,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Materiality,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Product Quality & Recall Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Risk & Crisis Management,84,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Supply Chain Management,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Tax Strategy,55,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Access to Healthcare,37,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Addressing Cost Burden,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,91,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Health Outcome Contribution,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Human Capital Development,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Labor Practice Indicators,97,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Occupational Health & Safety,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Social Reporting,89,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Talent Attraction & Retention,91,024468,BIIB,Biogen Inc.
4152157,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Change Governance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate Strategy Impacts,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Coverage of Environmental Management Policy,55,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,EP - Biological Oxygen Demand,31,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Energy Use,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Waste Disposal,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Water Use,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Diversity Policy,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Effectiveness,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,CEO Compensation - Success Metrics,47,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct: Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Compliance to Regulatory Standards,99,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing,39,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,ESG Integration in SCM Strategy,93,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Emerging Risks,47,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Material Issues for Enterprise Value Creation,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Open Innovation,57,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Opportunities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Process Innovations,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Product Innovations (Healthcare),73,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,R&D Post-Launch,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Responsibilities and Committees,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Service Orientation,95,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supplier Risk Management Measures,51,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supply Chain Risk Exposure,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Supply Chain Transparency & Reporting,60,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Taxation Governance & Risks,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Transparency of Executive Compensation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Access to Medicine Strategy Reporting,36,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Corporate Citizenship Strategy,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Development Programs,70,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Support Programs,63,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Gender Pay Indicators,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Governance,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,HTA Support of Value Proposition,50,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Health Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Capital Performance Indicators,40,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Assessment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Human Rights Mitigation & Remediation,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Labor KPIs - Layoffs,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Local Capacity Building,27,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,20,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Measure Contribution to Health Outcome,73,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Network Orientation,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Patent Filing Policy,0,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Social Reporting - Quantitative Data,67,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Trend of Employee Wellbeing,56,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Economic Governance Dimension,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Environmental Dimension,86,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Dimension,Social Dimension,76,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Climate Strategy,96,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Environmental Policy & Management Systems,80,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Operational Eco-Efficiency,74,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Innovation Management,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Marketing Practices,88,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Materiality,75,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Product Quality & Recall Management,100,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Risk & Crisis Management,84,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Supply Chain Management,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Tax Strategy,35,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Access to Healthcare,29,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Addressing Cost Burden,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,91,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Health Outcome Contribution,82,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Human Capital Development,78,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Labor Practice Indicators,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Occupational Health & Safety,83,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Social Reporting,89,024468,BIIB,Biogen Inc.
4152157,2016-09-08,Criteria,Talent Attraction & Retention,91,024468,BIIB,Biogen Inc.
4152157,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,84,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate Strategy - CDP Alignment,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Coverage of Environmental Management Policy,76,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,EP - Biological Oxygen Demand,28,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Energy Consumption,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Environmental Reporting - Quantitative Data,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Hazardous Waste,65,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Waste Disposal,28,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Water Consumption,81,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Effectiveness,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Industry Experience,50,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,CEO Compensation - Success Metrics,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Compliance to Regulatory Standards,99,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Contributions & Other Spending,33,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Emerging Risks,47,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Impact Valuation,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Largest Contributions & Expenditures,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Material Issues for Enterprise Value Creation,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Open Innovation,67,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Product Innovations (Healthcare),55,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supplier Risk Management Measures,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supply Chain Transparency & Reporting,42,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Taxation Governance & Risks,20,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Valuation Disclosure,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Support Programs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Gender Pay Indicators,98,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Governance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Assessment,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Mitigation & Remediation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Local Capacity Building,40,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Network Orientation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Quantitative Data,30,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Trend of Employee Wellbeing,56,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Environmental Dimension,85,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Social Dimension,89,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Climate Strategy,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Environmental Policy & Management Systems,86,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Environmental Reporting,98,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Operational Eco-Efficiency,69,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Business Ethics,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Corporate Governance,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Impact Measurement & Valuation,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Innovation Management,79,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Marketing Practices,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Materiality,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Policy Influence,44,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Product Quality & Recall Management,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Risk & Crisis Management,87,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Tax Strategy,35,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Access to Healthcare,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Human Rights,92,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Labor Practice Indicators,99,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Occupational Health & Safety,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Social Reporting,77,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Talent Attraction & Retention,91,024468,BIIB,Biogen Inc.
4152157,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,83,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate Strategy - CDP Alignment,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Coverage of Environmental Management Policy,76,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,EP - Biological Oxygen Demand,28,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Energy Consumption,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Environmental Reporting - Quantitative Data,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Hazardous Waste,65,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Waste Disposal,28,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Water Consumption,81,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Effectiveness,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Industry Experience,50,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,CEO Compensation - Success Metrics,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Compliance to Regulatory Standards,99,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Contributions & Other Spending,33,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Critical Supplier Identification,95,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Emerging Risks,47,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Expenses Associated with Product Recalls,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Impact Valuation,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Largest Contributions & Expenditures,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Management Ownership Requirements,83,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Material Issues for Enterprise Value Creation,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Open Innovation,67,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Product Innovations (Healthcare),55,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Core or Basic Research,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Ideation or Applied Research,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Responsibilities and Committees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Risks Correlation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supplier Risk Management Measures,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Supply Chain Transparency & Reporting,42,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Taxation Governance & Risks,20,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Valuation Disclosure,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Support Programs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Gender Pay Indicators,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Governance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Healthy Lifestyle Incentive,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Assessment,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Human Rights Mitigation & Remediation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Local Capacity Building,40,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Network Orientation,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Social Reporting - Quantitative Data,30,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Trend of Employee Wellbeing,56,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Environmental Dimension,85,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Dimension,Social Dimension,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Climate Strategy,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Environmental Policy & Management Systems,86,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Environmental Reporting,98,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Operational Eco-Efficiency,69,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Business Ethics,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Corporate Governance,80,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Impact Measurement & Valuation,0,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Innovation Management,79,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Marketing Practices,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Materiality,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Policy Influence,44,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Product Quality & Recall Management,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Risk & Crisis Management,87,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Tax Strategy,35,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Access to Healthcare,60,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Human Rights,92,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Labor Practice Indicators,75,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Occupational Health & Safety,93,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Social Reporting,77,024468,BIIB,Biogen Inc.
4152157,2017-09-07,Criteria,Talent Attraction & Retention,91,024468,BIIB,Biogen Inc.
4152157,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,84,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate Strategy - CDP Alignment,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,EMS: Certification/ Audit/ Verification,56,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,EP - Biological Oxygen Demand,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Emissions Reduction Targets,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Energy Consumption,95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Hazardous Waste,67,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Waste Disposal,35,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Water Consumption,69,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO-to-Employee Pay Ratio,51,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Compliance to Regulatory Standards,94,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Emerging Risks,35,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Family Ownership,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Management Ownership,24,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Material Issues for Enterprise Value Creation,84,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Open Innovation,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Product Innovations (Healthcare),85,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Core or Basic Research,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Ideation or Applied Research,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supplier Risk Management Measures,63,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supply Chain Transparency & Reporting,78,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Support Programs,58,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Gender Pay Indicators,69,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,HTA Support of Value Proposition,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Assessment,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Mitigation & Remediation,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Local Capacity Building,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Quantitative Data,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Trend of Employee Wellbeing,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Workforce Breakdown: Gender,68,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Environmental Dimension,86,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Social Dimension,89,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Climate Strategy,92,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Environmental Policy & Management Systems,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Operational Eco-Efficiency,79,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Business Ethics,83,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Corporate Governance,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Innovation Management,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Materiality,81,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Product Quality & Recall Management,74,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Risk & Crisis Management,74,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Supply Chain Management,72,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Access to Healthcare,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Addressing Cost Burden,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Health Outcome Contribution,83,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Human Rights,94,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Labor Practice Indicators,77,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Occupational Health & Safety,91,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Social Reporting,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Talent Attraction & Retention,95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,83,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate Strategy - CDP Alignment,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,EMS: Certification/ Audit/ Verification,56,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,EP - Biological Oxygen Demand,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Emissions Reduction Targets,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Energy Consumption,95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Hazardous Waste,67,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),95,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Waste Disposal,35,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Water Consumption,69,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Gender Diversity,58,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,CEO-to-Employee Pay Ratio,51,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Compliance to Regulatory Standards,94,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Emerging Risks,35,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Family Ownership,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Management Ownership,24,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Material Issues for Enterprise Value Creation,84,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Open Innovation,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Product Innovations (Healthcare),85,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Core or Basic Research,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Ideation or Applied Research,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supplier Risk Management Measures,63,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Supply Chain Transparency & Reporting,78,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Corporate Citizenship Strategy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Support Programs,58,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Gender Pay Indicators,0,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,HTA Support of Value Proposition,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Assessment,75,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Human Rights Mitigation & Remediation,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Local Capacity Building,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Social Reporting - Quantitative Data,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Trend of Employee Wellbeing,80,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Question,Workforce Breakdown: Gender,68,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Economic Governance Dimension,79,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Environmental Dimension,86,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Dimension,Social Dimension,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Climate Strategy,92,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Environmental Policy & Management Systems,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Operational Eco-Efficiency,79,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Business Ethics,83,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Corporate Governance,76,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Innovation Management,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Materiality,81,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Product Quality & Recall Management,74,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Risk & Crisis Management,74,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Supply Chain Management,72,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Access to Healthcare,70,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Addressing Cost Burden,87,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Health Outcome Contribution,83,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Human Rights,94,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Labor Practice Indicators,53,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Occupational Health & Safety,91,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Social Reporting,90,024468,BIIB,Biogen Inc.
4152157,2018-09-13,Criteria,Talent Attraction & Retention,95,024468,BIIB,Biogen Inc.
4152157,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,84,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Energy Consumption,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Hazardous Waste,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Waste Disposal,30,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Water Consumption,30,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Effectiveness,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Gender Diversity,38,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Type,85,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO-to-Employee Pay Ratio,60,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Compliance to Regulatory Standards,95,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Management Ownership,36,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Open Innovation,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Core or Basic Research,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Ideation or Applied Research,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supplier Risk Management Measures,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supply Chain Transparency & Reporting,78,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Access to Medicine Strategy Reporting,72,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corporate Citizenship Strategy,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Support Programs,43,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Gender Pay Indicators,69,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Capital Return on Investment,89,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Assessment,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Mitigation & Remediation,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Local Capacity Building,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Quantitative Data,93,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Trend of Employee Wellbeing,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Workforce Breakdown: Gender,76,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Social Dimension,86,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Climate Strategy,96,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Operational Eco-Efficiency,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Business Ethics,67,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Innovation Management,85,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Materiality,93,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Risk & Crisis Management,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Supply Chain Management,74,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Access to Healthcare,61,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,99,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Health Outcome Contribution,83,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Human Capital Development,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Human Rights,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Labor Practice Indicators,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Occupational Health & Safety,87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Social Reporting,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Talent Attraction & Retention,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,83,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Energy Consumption,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Hazardous Waste,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Waste Disposal,30,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Water Consumption,30,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Effectiveness,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Gender Diversity,38,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Board Type,85,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,CEO-to-Employee Pay Ratio,60,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Compliance to Regulatory Standards,95,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Management Ownership,36,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Materiality Analysis,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Open Innovation,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Core or Basic Research,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Development Stages,82,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Ideation or Applied Research,80,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Launch,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Risk Governance,40,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supplier Risk Management Measures,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Supply Chain Transparency & Reporting,78,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Access to Medicine Strategy Reporting,72,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Corporate Citizenship Strategy,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Support Programs,43,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Fair Pricing,88,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Gender Pay Indicators,0,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Capital Return on Investment,89,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Assessment,75,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Human Rights Mitigation & Remediation,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Local Capacity Building,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Measure Contribution to Health Outcome,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Social Reporting - Quantitative Data,93,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Trend of Employee Wellbeing,50,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Question,Workforce Breakdown: Gender,76,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Environmental Dimension,87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Dimension,Social Dimension,85,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Climate Strategy,96,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Operational Eco-Efficiency,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Business Ethics,67,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Innovation Management,85,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Materiality,93,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Risk & Crisis Management,70,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Supply Chain Management,74,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Access to Healthcare,61,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,99,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Health Outcome Contribution,83,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Human Capital Development,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Human Rights,81,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Labor Practice Indicators,55,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Occupational Health & Safety,87,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Social Reporting,98,024468,BIIB,Biogen Inc.
4152157,2019-09-13,Criteria,Talent Attraction & Retention,88,024468,BIIB,Biogen Inc.
4152157,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Climate Risk Management,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Energy Consumption,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Water Consumption,99,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Effectiveness,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Gender Diversity,22,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Type,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Compliance to Regulatory Standards,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Effective Tax Rate,99,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Measures,40,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,28,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Management Ownership,57,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Open Innovation,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Risk Governance,20,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supplier Risk Management Measures,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supply Chain Transparency & Reporting,42,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Access to Medicine Strategy Reporting,60,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corporate Citizenship Strategy,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Support Programs,75,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Fair Pricing,71,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Gender Pay Indicators,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Assessment,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Mitigation & Remediation,25,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Local Capacity Building,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Trend of Employee Wellbeing,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Workforce Breakdown: Gender,92,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Economic Governance Dimension,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Environmental Dimension,94,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Social Dimension,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Climate Strategy,91,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Operational Eco-Efficiency,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Corporate Governance,75,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,40,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Innovation Management,92,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Risk & Crisis Management,64,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Supply Chain Management,72,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Access to Healthcare,65,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Addressing Cost Burden,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,93,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Human Rights,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Labor Practice Indicators,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Occupational Health & Safety,94,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Talent Attraction & Retention,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Climate Risk Management,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Climate-Related Management Incentives,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Emissions Reduction Targets,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Energy Consumption,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Water Consumption,99,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Effectiveness,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Gender Diversity,22,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Board Type,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Compliance to Regulatory Standards,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Direct-to-Consumer Marketing,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Effective Tax Rate,99,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Measures,40,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,28,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Management Ownership,57,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Open Innovation,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Product Recalls (Health Care),100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Risk Governance,20,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supplier Risk Management Measures,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Supply Chain Transparency & Reporting,42,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Tax Strategy and Governance,0,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Access to Medicine Strategy Reporting,60,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Corporate Citizenship Strategy,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Support Programs,75,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Fair Pricing,71,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Gender Pay Indicators,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Capital Return on Investment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Assessment,85,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Due Diligence Process,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Human Rights Mitigation & Remediation,25,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Local Capacity Building,70,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Return on Employee Development Investment,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Trend of Employee Wellbeing,,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Question,Workforce Breakdown: Gender,92,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Economic Governance Dimension,80,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Environmental Dimension,94,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Dimension,Social Dimension,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Climate Strategy,91,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Operational Eco-Efficiency,95,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Business Ethics,82,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Corporate Governance,75,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,40,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Innovation Management,92,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Marketing Practices,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Risk & Crisis Management,64,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Supply Chain Management,72,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Tax Strategy,21,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Access to Healthcare,65,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Addressing Cost Burden,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,93,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Human Capital Development,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Human Rights,78,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Labor Practice Indicators,90,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Occupational Health & Safety,94,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2020-11-13,Criteria,Talent Attraction & Retention,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate Risk Assessment - Transition Risks,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate-Related Scenario Analysis,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,EMS: Certification/ Audit/ Verification,75,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Emissions Reduction Targets,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Energy Consumption,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Water Consumption,91,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Gender Diversity,44,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Industry Experience,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Type,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Compliance to Regulatory Standards,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Direct-to-Consumer Marketing,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Emerging Risks,50,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Governance,25,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Measures,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Management Ownership,75,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Open Innovation,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Product Recalls (Health Care),98,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Reporting on breaches,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Risk Governance,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supplier Risk Management Measures,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supply Chain Transparency & Reporting,86,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corporate Citizenship Strategy,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Discrimination & Harassment,50,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Support Programs,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Turnover Rate,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Fair Pricing,83,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Gender Pay Indicators,56,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Capital Return on Investment,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Due Diligence Process,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Local Capacity Building,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,People Analytics,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Strategic Workforce Planning,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Training & Development Inputs,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Trend of Employee Wellbeing,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Other Minorities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Environmental Dimension,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Social Dimension,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Climate Strategy,94,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Environmental Policy & Management Systems,87,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Operational Eco-Efficiency,83,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Business Ethics,86,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Corporate Governance,78,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,44,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Innovation Management,92,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Marketing Practices,73,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Risk & Crisis Management,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Access to Healthcare,77,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Addressing Cost Burden,94,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,93,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Human Capital Development,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Human Rights,62,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Labor Practice Indicators,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Occupational Health & Safety,73,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Talent Attraction & Retention,95,024468,BIIB,Biogen Inc.
4152157,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate Risk Assessment - Transition Risks,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Climate-Related Scenario Analysis,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,EMS: Certification/ Audit/ Verification,75,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Emissions Reduction Targets,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Energy Consumption,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Hazardous Waste,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Waste Disposal,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Water Consumption,91,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Gender Diversity,44,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Industry Experience,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Board Type,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Compliance to Regulatory Standards,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Direct-to-Consumer Marketing,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Emerging Risks,50,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Governance,25,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Measures,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Largest Contributions & Expenditures,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Management Ownership,75,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Open Innovation,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Product Recalls (Health Care),98,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Reporting on breaches,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Risk Governance,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supplier Code of Conduct,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supplier Risk Management Measures,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Supply Chain Transparency & Reporting,86,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Access to Medicine Strategy Reporting,54,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Corporate Citizenship Strategy,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Discrimination & Harassment,50,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Development Programs,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Support Programs,55,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Employee Turnover Rate,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Fair Pricing,83,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Gender Pay Indicators,56,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Capital Return on Investment,60,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Due Diligence Process,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Local Capacity Building,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,People Analytics,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Philanthropic Contributions,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Strategic Workforce Planning,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Training & Development Inputs,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Trend of Employee Wellbeing,,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Gender,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Other Minorities,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Economic Governance Dimension,81,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Environmental Dimension,90,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Dimension,Social Dimension,85,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Climate Strategy,94,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Environmental Policy & Management Systems,87,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Operational Eco-Efficiency,83,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Business Ethics,86,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Corporate Governance,78,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,44,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Innovation Management,92,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Marketing Practices,73,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Policy Influence,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Risk & Crisis Management,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Supply Chain Management,65,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Access to Healthcare,77,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Addressing Cost Burden,94,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,93,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Human Capital Development,84,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Human Rights,62,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Labor Practice Indicators,82,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Occupational Health & Safety,73,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2021-11-12,Criteria,Talent Attraction & Retention,95,024468,BIIB,Biogen Inc.
4152157,2022-09-23,S&P Global ESG Score,S&P Global ESG Score,79,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Biodiversity Commitment,21,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Climate Risk Assessment - Transition Risks,55,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Climate-Related Scenario Analysis,75,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Direct Greenhouse Gas Emissions (Scope 1),30,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,EMS: Certification/ Audit/ Verification,75,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Emissions Reduction Targets,90,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Energy Consumption,30,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Environmental Policy & Commitments,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Hazardous Waste,30,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Net-Zero Commitment,42,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,No Deforestation Commitment,,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Waste Disposal,80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Water Consumption,49,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Gender Diversity,27,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,CEO-to-Employee Pay Ratio,39,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Codes of Conduct: Systems/ Procedures,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Compliance to Regulatory Standards,97,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,IT Security/ Cybersecurity Measures,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,IT Security/ Cybersecurity Process & Infrastructure,40,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Largest Contributions & Expenditures,76,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Management Ownership,71,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Open Innovation,95,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Product Recalls (Health Care),97,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Reporting on breaches,10,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Risk Governance,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Supplier Code of Conduct,60,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Supplier Risk Management Measures,10,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Supply Chain Transparency & Reporting,84,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,UN Global Compact Membership,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Access to Healthcare Programs (Products & Drugs),20,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Corporate Citizenship Strategy,97,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Direct-to-Consumer Marketing,0,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Discrimination & Harassment,20,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Employee Development Programs,88,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Employee Support Programs,95,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Fair Pricing,87,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Gender Pay Indicators,95,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Human Capital Return on Investment,60,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Human Rights Due Diligence Process,55,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Impact on Access to Healthcare,0,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Local Capacity Building,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,OHS Policy,54,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,OHS Programs,0,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,People Analytics,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Philanthropic Contributions,80,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Strategic Workforce Planning,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Trend of Employee Wellbeing,43,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Workforce Breakdown: Gender,95,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Workforce Breakdown: Other Minorities,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Dimension,Economic Governance Dimension,84,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Dimension,Environmental Dimension,67,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Dimension,Social Dimension,77,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Biodiversity,21,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Climate Strategy,85,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Operational Eco-Efficiency,50,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Business Ethics,87,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Information Security/ Cybersecurity & System Availability,59,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Innovation Management,93,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Policy Influence,91,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Risk & Crisis Management,88,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Supply Chain Management,73,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Corporate Citizenship & Philanthropy,94,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Human Capital Development,83,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Human Rights,60,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Labor Practice Indicators,84,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Marketing Practices,73,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Occupational Health & Safety,55,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-09-23,Criteria,Talent Attraction & Retention,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,72,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Biodiversity Commitment,21,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate Risk Assessment - Transition Risks,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate-Related Scenario Analysis,75,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,EMS: Certification/ Audit/ Verification,75,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Emissions Reduction Targets,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Energy Consumption,30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Environmental Policy & Commitments,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Hazardous Waste,30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Net-Zero Commitment,42,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,No Deforestation Commitment,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Waste Disposal,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Water Consumption,49,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Gender Diversity,27,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO-to-Employee Pay Ratio,39,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Compliance to Regulatory Standards,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Measures,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,40,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Largest Contributions & Expenditures,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Management Ownership,71,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Open Innovation,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Product Recalls (Health Care),97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Reporting on breaches,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Risk Governance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supplier Code of Conduct,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supplier Risk Management Measures,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supply Chain Transparency & Reporting,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,UN Global Compact Membership,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),20,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corporate Citizenship Strategy,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Direct-to-Consumer Marketing,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Discrimination & Harassment,20,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Development Programs,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Support Programs,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Fair Pricing,87,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Gender Pay Indicators,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Capital Return on Investment,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Due Diligence Process,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Impact on Access to Healthcare,98,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Local Capacity Building,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,OHS Policy,54,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,OHS Programs,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,People Analytics,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Philanthropic Contributions,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Strategic Workforce Planning,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Trend of Employee Wellbeing,43,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Gender,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Other Minorities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Economic Governance Dimension,70,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Environmental Dimension,67,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Social Dimension,75,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Biodiversity,21,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Climate Strategy,85,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Operational Eco-Efficiency,50,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Business Ethics,28,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,59,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Innovation Management,93,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Policy Influence,91,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Risk & Crisis Management,29,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Supply Chain Management,73,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Access to Healthcare,70,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,94,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Human Capital Development,83,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Human Rights,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Labor Practice Indicators,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Marketing Practices,24,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Occupational Health & Safety,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Talent Attraction & Retention,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,71,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Biodiversity Commitment,21,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate Risk Assessment - Transition Risks,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate Risk Management,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate-Related Management Incentives,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Climate-Related Scenario Analysis,75,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,EMS: Certification/ Audit/ Verification,75,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Emissions Reduction Targets,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Energy Consumption,30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Environmental Policy & Commitments,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Environmental Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Hazardous Waste,30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Net-Zero Commitment,42,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,No Deforestation Commitment,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Waste Disposal,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Water Consumption,49,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Anti-Competitive Practices,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Average Tenure,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Gender Diversity,27,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Board Type,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO Compensation - Success Metrics,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,CEO-to-Employee Pay Ratio,39,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct: Coverage,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Compliance to Regulatory Standards,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corruption & Bribery Cases,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Critical Supplier Identification,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Dual Class Shares,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,ESG Integration in SCM Strategy,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Measures,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,40,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Largest Contributions & Expenditures,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Management Ownership,71,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Material Issues for Enterprise Value Creation,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Materiality Analysis,63,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Open Innovation,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Product Innovations (Healthcare),80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Product Recalls (Health Care),97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,R&D breakout by Innovation Phase,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Reporting on breaches,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Risk Governance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supplier Code of Conduct,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supplier Risk Management Measures,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supply Chain Risk Exposure,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Supply Chain Transparency & Reporting,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,UN Global Compact Membership,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),20,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Corporate Citizenship Strategy,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Direct-to-Consumer Marketing,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Discrimination & Harassment,20,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Development Programs,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Support Programs,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Fair Pricing,87,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Fatalities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Gender Pay Indicators,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Capital Return on Investment,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Due Diligence Process,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Impact on Access to Healthcare,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Local Capacity Building,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,OHS Policy,54,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,OHS Programs,0,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,People Analytics,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Philanthropic Contributions,80,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Social Reporting - Assurance,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Social Reporting - Coverage,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Strategic Workforce Planning,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Trend of Employee Wellbeing,43,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Type of Performance Appraisal,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Type of Philanthropic Activities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Gender,95,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Other Minorities,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Economic Governance Dimension,70,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Environmental Dimension,67,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Dimension,Social Dimension,72,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Biodiversity,21,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Climate Strategy,85,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Environmental Policy & Management Systems,90,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Environmental Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Operational Eco-Efficiency,50,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Business Ethics,28,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Corporate Governance,77,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,59,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Innovation Management,93,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Materiality,89,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Policy Influence,91,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Product Quality & Recall Management,97,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Risk & Crisis Management,29,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Supply Chain Management,73,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Access to Healthcare,45,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Addressing Cost Burden,96,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,94,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Human Capital Development,83,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Human Rights,60,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Labor Practice Indicators,84,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Marketing Practices,24,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Occupational Health & Safety,55,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Social Reporting,100,024468,BIIB,Biogen Inc.
4152157,2022-11-18,Criteria,Talent Attraction & Retention,88,024468,BIIB,Biogen Inc.
4152157,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,69,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Biodiversity Commitment,18,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Biodiversity Risk Assessment,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate Governance,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate Risk Management,81,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate-Related Management Incentives,60,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate-Related Scenario Analysis,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Emissions Reduction Targets,40,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Energy Consumption,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Environmental Policy & Commitments,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Exposure to Hazardous Substances,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Hazardous Waste,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Life Cycle Assessment,42,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Net-Zero Commitment,46,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,No Deforestation Commitment,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Design Criteria,32,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Waste Disposal,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Water Consumption,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Average Tenure,86,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Gender Diversity,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Independence,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Type,94,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO Compensation - Success Metrics,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Compliance to Regulatory Standards,98,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,83,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,KPIs for Supplier Assessment and Development,40,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,KPIs for Supplier Screening,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Largest Contributions & Expenditures,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Management Ownership,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Material Issues for Enterprise Value Creation,17,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Material Issues for External Stakeholders,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Analysis,25,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,47,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Open Innovation,85,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Innovations (Healthcare),70,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Recalls (Health Care),97,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,R&D breakout by Innovation Phase,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Governance,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Management Processes,45,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Assessment and Development,15,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Code of Conduct,43,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier ESG Program,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Screening,74,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Reporting Boundaries,75,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Taxonomies,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,UN Global Compact Membership,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),80,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Direct-to-Consumer Marketing,67,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Discrimination & Harassment,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Development Programs,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Support Programs,78,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Fair Pricing,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Fatalities,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Gender Pay Indicators,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Capital Return on Investment,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Due Diligence Process,70,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Impact on Access to Healthcare,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Local Capacity Building,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,OHS Policy,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,OHS Programs,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Trend of Employee Wellbeing,42,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Type of Performance Appraisal,85,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Workforce Breakdown: Gender,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Economic Governance Dimension,68,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Environmental Dimension,47,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Social Dimension,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Biodiversity,13,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Climate Strategy,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Environmental Policy & Management Systems,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Product Stewardship,43,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Business Ethics,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Corporate Governance,82,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,75,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Innovation Management,84,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Materiality,26,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Policy Influence,78,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Product Quality & Recall Management,98,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Risk & Crisis Management,34,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Supply Chain Management,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Access to Healthcare,66,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Addressing Cost Burden,93,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Human Capital Development,57,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Human Rights,64,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Labor Practice Indicators,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Marketing Practices,64,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Occupational Health & Safety,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Talent Attraction & Retention,83,024468,BIIB,Biogen Inc.
4152157,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,69,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Biodiversity Commitment,18,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Biodiversity Risk Assessment,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate Governance,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate Risk Management,81,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate-Related Management Incentives,60,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Climate-Related Scenario Analysis,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Coverage of Environmental Management Policy,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,EMS: Certification/ Audit/ Verification,81,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Emissions Reduction Targets,40,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Energy Consumption,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Environmental Policy & Commitments,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Exposure to Hazardous Substances,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Financial Opportunities Arising from Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Financial Risks of Climate Change,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Hazardous Waste,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Life Cycle Assessment,42,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Net-Zero Commitment,46,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,No Deforestation Commitment,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Physical Climate Risk Adaptation,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Design Criteria,32,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,TCFD Disclosure,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Waste Disposal,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Water Consumption,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Average Tenure,86,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Diversity Policy,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Effectiveness,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Gender Diversity,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Independence,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Industry Experience,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Board Type,94,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO Compensation - Success Metrics,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Codes of Conduct,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Compliance to Regulatory Standards,98,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Contributions & Other Spending,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Corruption & Bribery,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Effective Tax Rate,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Emerging Risks,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Family Ownership,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Government Ownership,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Governance,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,83,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,KPIs for Supplier Assessment and Development,40,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,KPIs for Supplier Screening,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Largest Contributions & Expenditures,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Management Ownership,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Management Ownership Requirements,60,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Material Issues for Enterprise Value Creation,17,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Material Issues for External Stakeholders,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Analysis,25,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,47,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Open Innovation,85,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Process Innovations,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Innovations (Healthcare),70,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Product Recalls (Health Care),97,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,R&D Spending,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,R&D breakout by Innovation Phase,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Reporting on breaches,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Culture,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Governance,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Risk Management Processes,45,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Assessment and Development,15,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Code of Conduct,43,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier ESG Program,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Supplier Screening,74,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Reporting Assurance,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Reporting Boundaries,75,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Sustainability Taxonomies,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Tax Reporting,0,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Tax Strategy and Governance,84,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,UN Global Compact Membership,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),80,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Direct-to-Consumer Marketing,67,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Discrimination & Harassment,20,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Development Programs,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Support Programs,78,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Employee Turnover Rate,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Ethical Marketing Commitment,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Fair Pricing,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Fatalities,90,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Freedom of Association,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Gender Pay Indicators,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,HTA Support of Value Proposition,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Hiring,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Capital Return on Investment,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Assessment,51,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Commitment,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Due Diligence Process,70,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Human Rights Mitigation & Remediation,34,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Impact on Access to Healthcare,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Local Capacity Building,30,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Long-Term Incentives for Employees,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Measure Contribution to Health Outcome,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,OHS Policy,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,OHS Programs,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Patent Filing Policy,,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Training & Development Inputs,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Trend of Employee Wellbeing,42,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Type of Performance Appraisal,85,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Workforce Breakdown: Gender,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Economic Governance Dimension,68,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Environmental Dimension,47,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Dimension,Social Dimension,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Biodiversity,13,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Climate Strategy,76,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Environmental Policy & Management Systems,92,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Product Stewardship,43,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Business Ethics,50,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Corporate Governance,82,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,75,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Innovation Management,84,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Materiality,26,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Policy Influence,78,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Product Quality & Recall Management,98,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Risk & Crisis Management,34,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Supply Chain Management,38,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Tax Strategy,63,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Access to Healthcare,66,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Addressing Cost Burden,93,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Health Outcome Contribution,88,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Human Capital Development,57,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Human Rights,64,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Labor Practice Indicators,79,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Marketing Practices,64,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Occupational Health & Safety,95,024468,BIIB,Biogen Inc.
4152157,2023-10-27,Criteria,Talent Attraction & Retention,83,024468,BIIB,Biogen Inc.
